INTREPID BIOSCIENCES Trademark
Trademark Overview
On Friday, February 11, 2022, a trademark application was filed for INTREPID BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the INTREPID BIOSCIENCES trademark a serial number of 97263723. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 16, 2023. This trademark is owned by Intrepid Biosciences, Inc.. The INTREPID BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceuticals for the treatment of autoimmune diseases
development for pharmaceutical preparations for the treatment of autoimmune diseases; scientific and clinical research, namely, drug development research in the field of autoimmune diseases
General Information
Serial Number | 97263723 |
Word Mark | INTREPID BIOSCIENCES |
Filing Date | Friday, February 11, 2022 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, October 16, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 17, 2023 |
Trademark Statements
Goods and Services | pharmaceuticals for the treatment of autoimmune diseases |
Disclaimer with Predetermined Text | "BIOSCIENCES" |
Goods and Services | development for pharmaceutical preparations for the treatment of autoimmune diseases; scientific and clinical research, namely, drug development research in the field of autoimmune diseases |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 16, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 16, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Intrepid Biosciences, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10022 |
Party Name | Intrepid Biosciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10022 |
Trademark Events
Event Date | Event Description |
Monday, October 16, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, October 16, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, March 14, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 17, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, December 28, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, December 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, December 9, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, December 9, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, December 9, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, December 5, 2022 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Monday, December 5, 2022 | PRIORITY ACTION E-MAILED |
Monday, December 5, 2022 | PRIORITY ACTION WRITTEN |
Monday, November 28, 2022 | ASSIGNED TO EXAMINER |
Wednesday, February 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, February 15, 2022 | NEW APPLICATION ENTERED |